Showing results (401-410 of 586) with videos related to
Sort By:
Pageof 59
Journal of Interventional Cardiology|May 29, 2003
Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary interventionJames E Tcheng, Mina Madan, J Conor O'Shea, et al.American Heart Journal|December 22, 2005
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registryTeresa L Kauf, Eric J Velazquez, David R Crosslin, et al.Cardiology|June 22, 2002
Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysisYochai Birnbaum, Kenneth W Mahaffey, Douglas A Criger, et al.The American Journal of Cardiology|February 19, 2004
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial)David E Kandzari, Christopher B Granger, Maarten L Simoons, et al.Heart (British Cardiac Society)|October 27, 2006
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroupsAdrián V Hernández, Cynthia M Westerhout, Ewout W Steyerberg, et al.The American Journal of Medicine|December 29, 2010
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic TherapyRajendra H Mehta, Amanda Stebbins, Renato D Lopes, et al.Journal of the American College of Cardiology|February 21, 2006
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromesSunil V Rao, Kristi O'Grady, Karen S Pieper, et al.Stroke|August 1, 2013
Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trialDavid Preiss, Thomas D Giles, Laine E Thomas, et al.Circulation|August 13, 2003
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet SubstudyVictor L Serebruany, Alexander H Glassman, Alex I Malinin, et al.European Heart Journal|August 30, 2011
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairmentKeith A A Fox, Jonathan P Piccini, Daniel Wojdyla, et al.Pageof 59